These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 6333485)

  • 1. Inhibition of autoimmune neuropathological process by treatment with an iron-chelating agent.
    Bowern N; Ramshaw IA; Clark IA; Doherty PC
    J Exp Med; 1984 Nov; 160(5):1532-43. PubMed ID: 6333485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of allergic encephalomyelitis by the iron chelating agent desferrioxamine: differential effect depending on type of sensitizing encephalitogen.
    Willenborg DO; Bowern NA; Danta G; Doherty PC
    J Neuroimmunol; 1988 Jan; 17(2):127-35. PubMed ID: 2447124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cardioprotector dexrazoxane augments therapeutic efficacy of mitoxantrone in experimental autoimmune encephalomyelitis.
    Weilbach FX; Chan A; Toyka KV; Gold R
    Clin Exp Immunol; 2004 Jan; 135(1):49-55. PubMed ID: 14678264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.
    Vandenbark AA; Gill T; Offner H
    J Immunol; 1985 Jul; 135(1):223-8. PubMed ID: 2582032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amelioration of experimental autoimmune encephalomyelitis in Lewis rats treated with fucoidan.
    Kim H; Moon C; Park EJ; Jee Y; Ahn M; Wie MB; Shin T
    Phytother Res; 2010 Mar; 24(3):399-403. PubMed ID: 19655293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.
    Kovarik J; Chabannes D; Borel JF
    Int J Immunopharmacol; 1995 Apr; 17(4):255-63. PubMed ID: 7545648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of experimental autoimmune encephalomyelitis in Lewis rats by antibodies against CD2.
    Jung S; Toyka K; Hartung HP
    Eur J Immunol; 1995 May; 25(5):1391-8. PubMed ID: 7539758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats.
    Jung S; Donhauser T; Toyka KV; Hartung HP
    J Autoimmun; 1997 Dec; 10(6):519-29. PubMed ID: 9451591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of novel immunosuppressant FK 506 in acute experimental allergic encephalomyelitis].
    Deguchi K; Takeuchi H; Miki H; Yamada A; Touge T; Terada S; Nishioka M
    No To Shinkei; 1990 Apr; 42(4):391-7. PubMed ID: 1697182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Chronic relapsing experimental allergic encephalomyelitis in Lewis rats as a model of multiple sclerosis].
    Zaprianova E; Deleva D; Bakalska M; Filchev N
    Morfologiia; 1997; 112(6):25-8. PubMed ID: 9606089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic effects of 15-deoxyspergualin in acute and chronic relapsing experimental allergic encephalomyelitis (EAE) as models for multiple sclerosis (MS).
    Schorlemmer HU; Seiler FR
    Drugs Exp Clin Res; 1991; 17(10-11):461-9. PubMed ID: 1841035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic effects of cisplatin on rat experimental autoimmune encephalomyelitis.
    Li XB; Schluesener HJ
    Arch Immunol Ther Exp (Warsz); 2006; 54(1):51-3. PubMed ID: 16642257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drugs of abuse and experimental autoimmune diseases.
    Lyman WD
    Adv Exp Med Biol; 1991; 288():81-92. PubMed ID: 1659140
    [No Abstract]   [Full Text] [Related]  

  • 14. Chronic neurologic dysfunction and demyelination induced in Lewis rats by repeated injections of encephalitogenic T-lymphocyte lines.
    Vandenbark AA; Nilaver G; Konat G; Teal P; Offner H
    J Neurosci Res; 1986; 16(4):643-56. PubMed ID: 2432277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoimmune effector cells. VII. Cells isolated from thymus and spinal cord of rats with experimental allergic encephalomyelitis transfer disease.
    Hayosh NS; Swanborg RH
    Am J Pathol; 1986 Feb; 122(2):218-22. PubMed ID: 2418687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of DAB(389)IL-2 immunotoxin on the course of experimental autoimmune encephalomyelitis in Lewis rats.
    Phillips SM; Bhopale MK; Constantinescu CS; Ciric B; Hilliard B; Ventura E; Lavi E; Rostami A
    J Neurol Sci; 2007 Dec; 263(1-2):59-69. PubMed ID: 17603081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A suppressor T-lymphocyte cell line for autoimmune encephalomyelitis.
    Ellerman KE; Powers JM; Brostoff SW
    Nature; 1988 Jan; 331(6153):265-7. PubMed ID: 2447505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines.
    Ben-Nun A; Cohen IR
    J Immunol; 1982 Mar; 128(3):1450-7. PubMed ID: 6173439
    [No Abstract]   [Full Text] [Related]  

  • 19. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoimmune effector cells. VI. Transfer of experimental allergic encephalomyelitis with spleen cells activated in mixed lymphocyte cultures.
    Hayosh NS; Simon LL; Swanborg RH
    J Immunol; 1984 Oct; 133(4):1943-5. PubMed ID: 6236261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.